September 17, 2025
September 16, 2025
Lebrikizumab 24-Week Trial in Skin of Color Atopic Dermatitis
September 12, 2025
FDA Considers Ending Routine Advisory Committees on New Drugs
September 12, 2025
Is Alopecia Areata a Marker of Elevated Cardiovascular Risk?
September 12, 2025
Cemiplimab Reduces Recurrence in High-Risk cSCC
September 12, 2025
Maternal Health and Vitiligo: First Scoping Review Protocol
Advertisement
Latest Headlines
View More
September 17, 2025
Global Survey Finds Suicidal Ideation Risk With Atopic Eczema
September 16, 2025
Lebrikizumab 24-Week Trial in Skin of Color Atopic Dermatitis
September 12, 2025
FDA Considers Ending Routine Advisory Committees on New Drugs
September 12, 2025
Is Alopecia Areata a Marker of Elevated Cardiovascular Risk?
September 12, 2025
Cemiplimab Reduces Recurrence in High-Risk cSCC
September 12, 2025
Maternal Health and Vitiligo: First Scoping Review Protocol
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
Conference Coverage
EADV Congress
September 17, 2025
Global Survey Finds Suicidal Ideation Risk With Atopic Eczema
2025 AACR Annual Meeting
2025 ASCO Annual Meeting
September 02, 2025